SNV4818, the oral drug, is pan-mutant–selective PI3K? inhibitor aimed at treating HR+/HER2- breast cancer and potentially other solid tumors
The initiative will be led by David Baker, 2024 Nobel Prize winner in Chemistry, IPD director, professor of biochemistry, and HHMI Investigator at the University of Washington
Vapendavir is an oral, potent, broad-spectrum antiviral active against rhinoviruses and related respiratory enteroviruses
India’s largest glycolic acid manufacturer will unveil AviGa Bio HP70 on April 14, 2026
The move aims to accelerate drug discovery with AI-driven designs powered by NVIDIA technology
The partnership is designed to close the gap between classroom learning and real-world pharmaceutical practice
A disinfectant credited with helping contain some of the world’s most dangerous livestock diseases is marking a major milestone
The partnership will focus on advancing fault-tolerant quantum algorithms and developing clinically relevant quantum applications
The Taipei facility boasts 10 GMP API production lines, with a total reactor volume exceeding 350,000 liters
The trial will enroll up to 42 patients in Finland across four cohorts
Subscribe To Our Newsletter & Stay Updated
